Inflammatory markers in older adults with respiratory infections
Part of Infections, Lungs & breathing clinical trials.
This study looks at how the body's immune system responds to common respiratory infections like flu, RSV, and COVID-19 in people aged 60 and older. It aims to understand inflammation during these infections, which could help improve future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 60 years of age or older.
- You have symptoms of a respiratory infection (like fever, cough, or congestion) that started within the last 1 to 3 days.
- You have tested positive for flu, RSV, or COVID-19 (or you are a healthy control without infection).
- You are not taking medications that suppress your immune system (except low-dose steroids).
- You do not have certain autoimmune diseases like lupus, rheumatoid arthritis, or multiple sclerosis.
- You are able to attend study visits as scheduled.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the immune system reacts to the flu in people of different ages. If you have flu symptoms and don't have cancer or take immune-suppressing drugs, you may be able to join.
This study looks at how the immune system in the nose and throat reacts to Streptococcus pneumoniae bacteria and viruses in adults aged 60-85. It may help researchers find better ways to prevent or treat pneumonia.
This study looks at how acute respiratory infections (like the flu, COVID-19, or RSV) affect older adults' daily functioning. If you are 60+ and in the hospital with one of these viruses, your participation would help doctors understand the lasting impact on independence and health.
This study examines how the body's natural defense system (specifically a type of immune protein) responds to common respiratory viruses like flu and cold in older adults. Researchers will analyze nasal samples that are already being collected as part of routine care to better understand why older people sometimes have different immune responses to these infections.
This study looks at older adults (60+) who are in the hospital with lung or breathing infections caused by viruses. It aims to better understand these infections in older people, which may help improve care and treatment for patients like you.
This study tests how older adults' immune systems respond to a mild RSV virus given as a nasal spray. It helps researchers understand RSV and may lead to better vaccines or treatments.
Hear when a new SARS CoV 2 Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.